Subscribe To
Blackrock: a dividend grower on sale
BlackRock's assets under management (AUM) have fallen due to overall market weakness, but the company's latest earnings were decent overall. AUM was u...
November 2, 2023, 5:56 pm
Brookfield infrastructure's valuation and ffo are not a reason to sell
BIP has delivered exceptional long-term distribution growth while also maintaining a strong balance she...
November 2, 2023, 5:56 pm
'this was a real yawner of a quarter' for apple, says annandale's george seay
George Seay, Annandale Capital founder, and Stephanie Link, Hightower chief investment strategist, join 'Closing Bell Overtime' with reacti...
November 2, 2023, 5:50 pm
Paramount outpaces expectations, adding subscribers and narrowing streaming losses
Paramount+ adds 2.7 million subscribers and streaming losses fall from $343 milli...
November 2, 2023, 5:50 pm
Gold, silver, platinum forecasts – gold moves higher as dollar pulls back
U.S. dollar’s pullback did not provide support to silver and platinum. The post Gold, Silver, Platinum Forecasts – Gold Moves Higher As Dollar Pul...
November 2, 2023, 5:45 pm
Qtec: a time for equal weighting tech
QTEC is an ETF that passively manages assets worth over $2.7 billion and aims to track the performance ...
November 2, 2023, 5:44 pm
Switzerland to send chf 90m in aid to the middle-east
The Swiss Government will ask Parliament to release CHF 90m in aid for the victims of the Isreaeli-Palestinian conflict. Read Full Story at source (ma...
November 2, 2023, 5:44 pm
Aud/usd: hawkish rba and china’s new budget
A notable end to last week saw the AUD/USD outperform, despite a wave of risk-aversion flows that hit t...
November 2, 2023, 5:44 pm
Innovative industrial properties, inc. (iipr) q3 2023 earnings call transcript
Innovative Industrial Properties, Inc. (NYSE:IIPR ) Q3 2023 Earnings Conference Call November 2, 2023 1:00 PM ET Company Participants Brian Wolfe - Ge...
November 2, 2023, 5:43 pm
These 3 companies are poised for explosive growth in 2024
The outlook for 2024 may be a bit uncertain due to current macroeconomic and geopolitical events, not to menti...
November 2, 2023, 5:42 pm
Why ionq stock made a quantum drop last month
IonQ's stock experienced a substantial 35.2% drop in October, mainly due to the departure of its co-founder and chief science officer. Despite this se...
November 2, 2023, 5:42 pm
Biv: a time to finally allocate
Investing in bond ETFs has been challenging, but that may change as bonds become a great diversifier. Vanguard Intermediate-Term Bond Index Fund ETF S...
November 2, 2023, 5:41 pm
Apple q4 sales fall as big drop in mac, ipad revenue offsets rise in iphone sales
Apple faces an uneven economic recovery in China, a key market for Apple....
November 2, 2023, 5:39 pm
Coinbase trading volume decline overshadows 3q earnings beat
Coinbase Global Inc (NASDAQ:COIN) reported third quarter earnings that topped estimates but investors were left disappointed by a decline in trading v...
November 2, 2023, 5:39 pm
Black hills corporation (bkh) q3 2023 earnings call transcript
Black Hills Corporation (NYSE:BKH ) Q3 2023 Earnings Conference Call November 2, 2023 11:00 AM ET Compa...
November 2, 2023, 5:39 pm
S&p 500 gains and losses today: starbucks shares jump following profit record
U.S. equities posted strong gains Thursday, with the S&P 500 rising 1.9% amid optimism that the Federal Reserve might be finished raising interest rat...
November 2, 2023, 5:35 pm
Cloudflare's stock drops after earnings as forecast comes up a bit shy
Cloudflare Inc. shares were declining 6% in Thursday's extended session after the cybersecurity company...
November 2, 2023, 5:35 pm
Atlassian sinks despite better-than-expected results and inline forecast
Atlassian beat on the top and bottom lines and issued a forecast that met analysts' estimates...
November 2, 2023, 5:34 pm
Janus henderson: downside concerns eased, buy rating reinstated
Janus Henderson reported a solid 3Q23 result, with key operational trends ahead of expectations. The an...
November 2, 2023, 5:34 pm
Regenxbio: biotech to watch with 2 possible accelerated approval pathways
Regenxbio Inc. is making progress in its pipeline, aiming to have five gene therapies in late-stage testing or approved by 2025. The company's lead ca...
November 2, 2023, 5:33 pm